NO931956L - Imidoesterkryssbundne hemoglobinpreparater - Google Patents

Imidoesterkryssbundne hemoglobinpreparater

Info

Publication number
NO931956L
NO931956L NO93931956A NO931956A NO931956L NO 931956 L NO931956 L NO 931956L NO 93931956 A NO93931956 A NO 93931956A NO 931956 A NO931956 A NO 931956A NO 931956 L NO931956 L NO 931956L
Authority
NO
Norway
Prior art keywords
cross
imidoster
hemoglobin preparations
oxygen
bonded
Prior art date
Application number
NO93931956A
Other languages
English (en)
Norwegian (no)
Other versions
NO931956D0 (no
Inventor
Robert Lee Garlick
Jr Joseph Patrick Martin
Stephen Baker Lyle
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO931956L publication Critical patent/NO931956L/no
Publication of NO931956D0 publication Critical patent/NO931956D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO931956A 1990-11-29 1993-05-28 Imidoesterkryssbundne hemoglobinpreparater NO931956D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61984090A 1990-11-29 1990-11-29
PCT/US1991/007155 WO1992009630A1 (fr) 1990-11-29 1991-10-03 Compositions d'hemoglobine reticulees par un imidoester

Publications (2)

Publication Number Publication Date
NO931956L true NO931956L (no) 1993-05-28
NO931956D0 NO931956D0 (no) 1993-05-28

Family

ID=24483529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931956A NO931956D0 (no) 1990-11-29 1993-05-28 Imidoesterkryssbundne hemoglobinpreparater

Country Status (22)

Country Link
US (2) US5362855A (fr)
EP (1) EP0559655B1 (fr)
JP (1) JPH06502848A (fr)
AT (1) ATE119917T1 (fr)
AU (1) AU650287B2 (fr)
CA (1) CA2093650A1 (fr)
CZ (1) CZ281912B6 (fr)
DE (1) DE69108258T2 (fr)
DK (1) DK0559655T3 (fr)
ES (1) ES2069908T3 (fr)
FI (1) FI932461A (fr)
HU (2) HUT64571A (fr)
IE (1) IE914144A1 (fr)
IL (1) IL99785A (fr)
MX (1) MX9102239A (fr)
NO (1) NO931956D0 (fr)
NZ (1) NZ240377A (fr)
PL (1) PL167340B1 (fr)
PT (1) PT99666A (fr)
SK (1) SK54993A3 (fr)
WO (1) WO1992009630A1 (fr)
ZA (1) ZA918348B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0646130B1 (fr) * 1993-03-16 1996-12-11 Hemosol Inc. Reticulation selective d'hemoglobines par des saccharides oxydes a cycle ouvert
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
DE4418973A1 (de) * 1994-05-31 1995-12-14 Barnikol Wolfgang Verfahren zur Herstellung molekular-einheitlicher hyperpolymerer Hämoglobine
US6150507A (en) * 1995-03-23 2000-11-21 Biopure Corporation Method for producing a purified hemoglobin product
US5981716A (en) * 1995-06-07 1999-11-09 Gruppo Lepettit, S.P.A. Process for the purification of proteins
FR2736930B1 (fr) * 1995-07-17 1997-09-19 Biocem Procede de production, par des cellules vegetales, de proteines heminiques, proteines ainsi obtenues et produits contenant ces proteines
US5872015A (en) * 1996-05-10 1999-02-16 Board Of Trustees Of The University Of Illinois Molecular diversity screening method
EP0941130B1 (fr) * 1996-11-05 2003-03-26 Challenge Bioproducts Co., Ltd. Modification chimique de materiaux biomedicaux par la genipine
US7282220B1 (en) 1996-11-05 2007-10-16 Hsing-Wen Sung Genipin-crosslinked gelatin microspheres as drug carrier
US6949384B2 (en) * 2001-12-21 2005-09-27 Spectromedical Inc. Method for monitoring degradation of Hb-based blood substitutes
US7449339B2 (en) * 1999-11-23 2008-11-11 Nir Diagnostics Inc. Spectroscopic method and apparatus for total hemoglobin measurement
CN100431602C (zh) * 2003-01-29 2008-11-12 北原实验室有限公司 具有低量四聚体的聚合血红蛋白溶液及制备方法
US7135554B1 (en) * 2004-01-27 2006-11-14 Biopure Corporation Method of forming a polymerized hemoglobin solution from stabilized hemoglobin
DE102011105525B4 (de) * 2011-06-24 2015-03-26 Sartorius Stedim Biotech Gmbh Verfahren zur Abtrennung von Biopolymer-Aggregaten und Viren aus einem Fluid
WO2019018403A1 (fr) 2017-07-18 2019-01-24 Virtech Bio, Llc Substituts sanguins comprenant de l'hémoglobine et procédés de fabrication
CN111989568B (zh) * 2018-04-18 2024-05-28 积水医疗株式会社 血红蛋白分析方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925344A (en) * 1973-04-11 1975-12-09 Community Blood Council Plasma protein substitute
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
DE3144705C2 (de) * 1981-11-11 1983-12-08 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines lagerstabilen, vernetzten Hämoglobinpräparates mit hoher Sauerstoff-Transportkapazität, sowie das nach diesem Verfahren hergestellte Hämoglobinpräparat
US4600531A (en) * 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4711852A (en) * 1984-11-05 1987-12-08 Akzo N.V. Control for blood gas analyzers and hemoglobin analysis
US4826811A (en) * 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
WO1988003408A1 (fr) * 1986-11-10 1988-05-19 Biopure Corporation Succedane du sang semi-synthetique extra pur
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
IL87708A (en) * 1988-09-08 1994-04-12 Technion Inst For Research And Hemoglobin-based blood substitute possessing a colloid oncotic pressure substantially similar to human blood and method for the preparation thereof

Also Published As

Publication number Publication date
WO1992009630A1 (fr) 1992-06-11
IL99785A (en) 1996-05-14
ZA918348B (en) 1993-04-19
HUT64571A (en) 1994-01-28
US5362855A (en) 1994-11-08
AU650287B2 (en) 1994-06-16
PT99666A (pt) 1992-10-30
AU8546691A (en) 1992-06-25
MX9102239A (es) 1992-07-08
US5521154A (en) 1996-05-28
PL167340B1 (pl) 1995-08-31
EP0559655A1 (fr) 1993-09-15
FI932461A0 (fi) 1993-05-28
IE914144A1 (en) 1992-06-03
ATE119917T1 (de) 1995-04-15
NZ240377A (en) 1993-01-27
DE69108258T2 (de) 1995-08-10
IL99785A0 (en) 1992-08-18
DK0559655T3 (da) 1995-07-24
HU211703A9 (en) 1995-12-28
ES2069908T3 (es) 1995-05-16
FI932461A (fi) 1993-05-28
HU9301563D0 (en) 1993-09-28
CA2093650A1 (fr) 1992-05-30
CZ85493A3 (en) 1994-02-16
CZ281912B6 (cs) 1997-03-12
SK54993A3 (en) 1993-10-06
EP0559655B1 (fr) 1995-03-15
JPH06502848A (ja) 1994-03-31
DE69108258D1 (de) 1995-04-20
NO931956D0 (no) 1993-05-28

Similar Documents

Publication Publication Date Title
NO931956L (no) Imidoesterkryssbundne hemoglobinpreparater
NO904456L (no) Fremgangsmaate for fremstilling av liposomer og/eller biologiske celler, i hvilke er inkludert tilsetningstoffer, oganvendelse derav.
DE3851225D1 (de) Blutersatz.
DK0695408T3 (da) Fremgangsmåde til forbedring af celluloseholdige produkters modstandsevne over for skimmel og råd
Stoner Studies on the mechanism of shock: the impairment of thermoregulation by trauma
IL87707A0 (en) Hemoglobin-based blood substitute and method for the preparation thereof
FI88931B (fi) Nya enzymer foer uppspjaelkning av lignin
Labat et al. Vasorelaxant effects of atrial peptide II on isolated human pulmonary muscle preparations
Massa et al. Endothelium-dependent relaxation after short-term preservation of vascular grafts
DE3271788D1 (en) Ultrafiltering hybrid artificial organ
DK0609242T3 (da) Nyt thrombininhibitorisk protein fra blodmider
SE9301324D0 (sv) New method of treatment
SUZUKI et al. Comparison of several methods for the determination of sulphites in foods
Menu et al. Importance of purification on transfusional efficacy of hemoglobin solutions
Bulman Dictyonema from the Tremadocian of Estonia and Norway
RU93034458A (ru) Композиция гемоглобина, поперечно связанного с имидоэфиром, и способ ее получения
Schaff et al. Myocardial ischemia distal to critical coronary stenosis during cardiopulmonary bypass: fibrillating vs beating nonworking heart
Siepmann Pathogenicity tests with Calocera viscosa.
He et al. Age-related differences in the effect of vasodilator substances on coronary flow in perfused rabbit hearts
Zhu et al. The role of lipid peroxidation in endotoxin-induced lung injury in goats.
Mitchell Phoenix 71-84 and 424-42: Two Syntactical Cruces Involving Punctuation
Watts et al. Nisoldipine protects endothelial cell dependent vasodilation against injury from ischemia and reperfusion in rat hearts
Gil-Longo et al. G-proteins from cultured bovine aortic endothelial cells
Reed et al. Zapping a curmudgeon.
Kamo Studies on Surgical Treatment of far Advanced Pulmonary Tuberculosis 2. Indication for Surgery, with special reference to functional limit for opearation